Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-10

FDA Approved: ONDANSETRON — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for ondansetron hydrochloride (ondansetron), a generic product manufactured by Fresenius Kabi USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron hydrochloride (ondansetron hydrochloride)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON HYDROCHLORIDE)